Trial NCT04283461; NCT04785144
Publication Anderson E, SSRN, 2022
Primary outcome on the report: Safety and immunogenicity after a third mRNA vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.